190 related articles for article (PubMed ID: 35382253)
21. Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis.
Helbig G; Widuchowska M; Koclęga A; Kopińska A; Kopeć-Mędrek M; Gaweł WB; Spałek A; Żak J; Grygoruk-Wiśniowska I; Liwoch R; Kucharz E; Markiewicz M
Clin Rheumatol; 2018 Jun; 37(6):1709-1714. PubMed ID: 29256111
[TBL] [Abstract][Full Text] [Related]
22. Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis.
Shouval R; Furie N; Raanani P; Nagler A; Gafter-Gvili A
Biol Blood Marrow Transplant; 2018 May; 24(5):937-944. PubMed ID: 29374527
[TBL] [Abstract][Full Text] [Related]
23. Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.
Sullivan KM; Majhail NS; Bredeson C; Carpenter PA; Chatterjee S; Crofford LJ; Georges GE; Nash RA; Pasquini MC; Sarantopoulos S; Storek J; Savani B; St Clair EW
Biol Blood Marrow Transplant; 2018 Oct; 24(10):1961-1964. PubMed ID: 29953945
[TBL] [Abstract][Full Text] [Related]
24. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
Burt RK; Shah SJ; Dill K; Grant T; Gheorghiade M; Schroeder J; Craig R; Hirano I; Marshall K; Ruderman E; Jovanovic B; Milanetti F; Jain S; Boyce K; Morgan A; Carr J; Barr W
Lancet; 2011 Aug; 378(9790):498-506. PubMed ID: 21777972
[TBL] [Abstract][Full Text] [Related]
25. Autologous hematopoietic stem cell transplantation in autoimmune diseases.
Annaloro C; Onida F; Lambertenghi Deliliers G
Expert Rev Hematol; 2009 Dec; 2(6):699-715. PubMed ID: 21082959
[TBL] [Abstract][Full Text] [Related]
26. Stem Cell Therapy as a Treatment for Autoimmune Disease-Updates in Lupus, Scleroderma, and Multiple Sclerosis.
Ramalingam S; Shah A
Curr Allergy Asthma Rep; 2021 Mar; 21(3):22. PubMed ID: 33759038
[TBL] [Abstract][Full Text] [Related]
27. Optimization of autologous stem cell transplantation for systemic sclerosis -- a single-center longterm experience in 26 patients with severe organ manifestations.
Henes JC; Schmalzing M; Vogel W; Riemekasten G; Fend F; Kanz L; Koetter I
J Rheumatol; 2012 Feb; 39(2):269-75. PubMed ID: 22247352
[TBL] [Abstract][Full Text] [Related]
28. Stem cell transplantation for severe autoimmune diseases: progress and problems.
Marmont AM
Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258
[TBL] [Abstract][Full Text] [Related]
29. Adult stem cell treatment of scleroderma.
Tyndall A; Furst DE
Curr Opin Rheumatol; 2007 Nov; 19(6):604-10. PubMed ID: 17917542
[TBL] [Abstract][Full Text] [Related]
30. [Cardiopulmonary function before and after cyclophosphamide treatment in severe systemic sclerosis: comparison of monthly intravenous bolus and autologous haematopoietic stem cell transplantation].
Toledano C; Henegar C; Ilie D; Launay D; Tiev K; Marie I; Marjanovic Z; Emmerich J; Cabane J; Ménasché S; Farge D
Rev Med Interne; 2005 Jun; 26(6):444-52. PubMed ID: 15936473
[TBL] [Abstract][Full Text] [Related]
31. The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders.
Rebeiro P; Moore J
Intern Med J; 2016 Jan; 46(1):17-28. PubMed ID: 26524106
[TBL] [Abstract][Full Text] [Related]
32. Haematopoietic stem cell transplantation for the treatment of systemic sclerosis and other autoimmune disorders.
Tyndall A; Matucci-Cerinic M
Expert Opin Biol Ther; 2003 Oct; 3(7):1041-9. PubMed ID: 14519069
[TBL] [Abstract][Full Text] [Related]
33. Hematopoietic stem cell transplantation for systemic sclerosis: Brazilian experience.
Henrique-Neto Á; Vasconcelos MYK; Dias JBE; de Moraes DA; Gonçalves MS; Zanin-Silva DC; Zucoloto TG; de Oliveira MFC; Dotoli GM; Weffort LF; Leopoldo VC; Oliveira MC
Adv Rheumatol; 2021 Feb; 61(1):9. PubMed ID: 33549135
[TBL] [Abstract][Full Text] [Related]
34. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
Kyle RA
Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
[TBL] [Abstract][Full Text] [Related]
35. Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.
Casanova B; Jarque I; Gascón F; Hernández-Boluda JC; Pérez-Miralles F; de la Rubia J; Alcalá C; Sanz J; Mallada J; Cervelló A; Navarré A; Carcelén-Gadea M; Boscá I; Gil-Perotin S; Solano C; Sanz MA; Coret F
Neurol Sci; 2017 Jul; 38(7):1213-1221. PubMed ID: 28396953
[TBL] [Abstract][Full Text] [Related]
36. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
Binks M; Passweg JR; Furst D; McSweeney P; Sullivan K; Besenthal C; Finke J; Peter HH; van Laar J; Breedveld FC; Fibbe WE; Farge D; Gluckman E; Locatelli F; Martini A; van den Hoogen F; van de Putte L; Schattenberg AV; Arnold R; Bacon PA; Emery P; Espigado I; Hertenstein B; Hiepe F; Kashyap A; Kötter I; Marmont A; Martinez A; Pascual MJ; Gratwohl A; Prentice HG; Black C; Tyndall A
Ann Rheum Dis; 2001 Jun; 60(6):577-84. PubMed ID: 11350846
[TBL] [Abstract][Full Text] [Related]
37. [Autologous stem cell transplantation in systemic sclerosis].
Henes JC; Wirths S; Kötter I
Z Rheumatol; 2016 Oct; 75(8):762-769. PubMed ID: 27510996
[TBL] [Abstract][Full Text] [Related]
38. Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis.
Saccardi R; Tyndall A; Coghlan G; Denton C; Edan G; Emdin M; Farge D; Fassas A; Finke J; Furst D; Lassus M; Mancardi G; Miniati I; Mini E; Pagliai F; Passweg J; Pignone A; van Laar JM; Bocelli-Tyndall C; Matucci-Cerinic M
Bone Marrow Transplant; 2004 Nov; 34(10):877-81. PubMed ID: 15517007
[TBL] [Abstract][Full Text] [Related]
39. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
Watt SM; Austin E; Armitage S
Methods Mol Biol; 2007; 368():237-59. PubMed ID: 18080475
[TBL] [Abstract][Full Text] [Related]
40. [Immunoablation or otherwise followed by hematopoietic cell stem as intensive treatment of severe autoimmune diseases].
du Haut Champ AM
Ann Ital Med Int; 2002; 17(1):11-20. PubMed ID: 11975110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
